No link to cardiac valvulopathy was seen in cabergoline treated patients
<p><strong>Objective:</strong> To evaluate the association between use of cabergoline in patients with prolactinoma and risk of developing clinically relevant cardiac valvular disease.</p> <p><strong>Method:</strong> This was a descriptive cross sectional st...
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Sri Lanka College of Endocrinologists
2012-10-01
|
| Edice: | Sri Lanka Journal of Diabetes Endocrinology and Metabolism |
| Témata: | |
| On-line přístup: | https://sjdem.sljol.info/articles/4775 |